LETROBOL contains Letrozole 2.5 mg, an oral aromatase
inhibitor used to lower estrogen levels. It is widely used in managing
hormone-dependent breast cancer in postmenopausal women. This medication
supports treatment progression, reduces recurrence risk, and may be part of a
long-term therapeutic plan under medical supervision.
Uses
Treatment of hormone-responsive breast cancer
Reduces estrogen production in the body
Used after initial cancer treatment to prevent
recurrence
Sometimes prescribed before surgery to shrink tumors
for operability
May be used in selected fertility-related treatments
under specialist care
